Walter Bushnell Medisafe Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-07-2024
- Paid Up Capital ₹ 0.10 M
as on 30-07-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -2.11%
(FY 2023)
- Profit -134.01%
(FY 2023)
- Ebitda -62.97%
(FY 2023)
- Net Worth -7.75%
(FY 2023)
- Total Assets -7.25%
(FY 2023)
About Walter Bushnell Medisafe
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Murgai, Prakash Sabherwal, and Prabhudas Gohil serve as directors at the Company.
- CIN/LLPIN
U24232PB2008PTC053431
- Company No.
175851
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mohali, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Walter Bushnell Medisafe?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satish Murgai | Director | 25-Mar-2008 | Current |
Prakash Sabherwal | Director | 25-Mar-2008 | Current |
Prabhudas Gohil | Director | 29-May-2019 | Current |
Financial Performance and Corporate Structure Insights of Walter Bushnell Medisafe.
Walter Bushnell Medisafe Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.11% decrease. The company also saw a substantial fall in profitability, with a 134.01% decrease in profit. The company's net worth dipped by a decrease of 7.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Walter Bushnell Medisafe?
In 2023, Walter Bushnell Medisafe had a promoter holding of 99.59% and a public holding of 0.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Walter Bushnell Lifescience Private LimitedActive 2 years 9 months
Prabhudas Gohil is a mutual person
- Walter Bushnell Pharmaceuticals Private LimitedActive 20 years 10 days
Satish Murgai is a mutual person
- Walter Bushnell Healthsciences Private LimitedActive 17 years 5 months
Prakash Sabherwal and Prabhudas Gohil are mutual person
- Walter Bushnell Biosciences Private LimitedActive 17 years 5 months
Prakash Sabherwal and Prabhudas Gohil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Walter Bushnell Medisafe?
Walter Bushnell Medisafe has a workforce of 66 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Walter Bushnell Medisafe, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walter Bushnell Medisafe's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.